We also find increased (serum) IL-10 in PF patients prior to IFN-α treatment, and an exaggerated response in IL-10 and IL-6 to IFN-α during treatment, with higher levels driven by a greater increase in the first four weeks. The gene discussed is IL10; the disease is pemphigus foliaceus.